Next Article in Journal
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children
Next Article in Special Issue
A Novel Ligustrazine Derivative T-VA Prevents Neurotoxicity in Differentiated PC12 Cells and Protects the Brain against Ischemia Injury in MCAO Rats
Previous Article in Journal
Wnt3a Promotes the Vasculogenic Mimicry Formation of Colon Cancer via Wnt/β-Catenin Signaling
Previous Article in Special Issue
Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2015, 16(8), 18580-18600; doi:10.3390/ijms160818580

Evaluation and Management of Neurogenic Bladder: What Is New in China?

1,2,3,4
1
Department of Urology, China Rehabilitation Research Center, Beijing 100068, China
2
Department of Urology, Capital Medical University, Beijing 100069, China
3
Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing 100068, China
4
Beijing Key Laboratory of Neural Injury and Rehabilitation, Beijing 100068, China 
Academic Editor: Katalin Prokai-Tatrai
Received: 18 June 2015 / Revised: 23 July 2015 / Accepted: 23 July 2015 / Published: 10 August 2015
(This article belongs to the Collection Neuroprotective Strategies)
View Full-Text   |   Download PDF [2111 KB, uploaded 10 August 2015]   |  

Abstract

Neurogenic bladder (NB) or neurogenic lower urinary tract dysfunction (NLUTD), a dysfunction of the urinary bladder and urethra due to disease of the central nervous system or peripheral nerves, is a major global medical and social problem. Numerous nervous system abnormalities, such as: stroke, Alzheimer’s and Parkinson’s diseases, traumatic spinal cord injury, spinal cord tumors, congenital spina bifida, and diabetes, can cause NB/NLUTD. There are two major types of bladder control problems associated with NB/NLUTD: the bladder becomes either overactive or underactive depending on the nature, level, and extent of nerve damage. This review specifically focuses on the diagnosis and management of NB/NLUTD in China as well as on recent efforts to treat this disease. View Full-Text
Keywords: neurogenic bladder; neurogenic lower urinary tract dysfunction; central nervous system abnormalities; peripheral nerve damage; diagnosis; treatment neurogenic bladder; neurogenic lower urinary tract dysfunction; central nervous system abnormalities; peripheral nerve damage; diagnosis; treatment
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Liao, L. Evaluation and Management of Neurogenic Bladder: What Is New in China? Int. J. Mol. Sci. 2015, 16, 18580-18600.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top